Telitacicept
RemeGen
['telitacicept']
efficacy and safety of telitacicept, a novel blys/april dual inhibitor, in patients with primary sj gren s syndrome: a phase 2, randomized, placebo-controlled 24-week study" #eular2023 #sjogren dr. van vollenhoven 
Reumatologia. rheumatologist MFiC. Esclerosis Sistémica. EAS. SPA. PNL. TBE